<DOC>
	<DOCNO>NCT02448784</DOCNO>
	<brief_summary>To investigate long term safety ( especially Parkinsonism ) efficacy donepezil hydrochloride clinical practice well proper use information participant DLB .</brief_summary>
	<brief_title>Post-marketing Surveillance Donepezil Hydrochloride - Investigation Long Term Safety Efficacy Aricept Well Its Proper Use Information Patients With Dementia With Lewy Bodies ( DLB ) .</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Lewy Body Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>1 . Naive participant diagnose DLB 1 . Participants history donepezil hydrochloride product administration past 2 . Participants already register surveillance 3 . Participants history hypersensitivity ingredient donepezil hydrochloride piperidine derivative</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Donepezil Hydrochloride</keyword>
	<keyword>ARICEPT</keyword>
	<keyword>Dementia</keyword>
	<keyword>Lewy body</keyword>
	<keyword>Dementia Lewy body</keyword>
	<keyword>Post-marketing surveillance</keyword>
</DOC>